Dr Noel Alpins
Ophthalmology and its associated advanced technologies has continuously evolved to help physi-cians diagnose and treat conditions and diseases more effectively. However, major advances and their innovators frequently face initial undue criticism or disinterest, even from the profession’s leaders who should be trying to encourage new ideas. Like all fields of science and medicine, oph-thalmology has proven to have an ingrained culture of, initially at least, attempting to preserve the status quo.
This lecture will discuss why resistance to change prevents ophthalmologists from achieving the highest standards of care for patients. Every practitioner should be encouraged to contribute to innovation for the sake of improving techniques and getting better outcomes for patients.
“Innovation is the ability to see change as an opportunity – not a threat” Anon
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY